Allergan Inc
AGN
AGN was delisted on the 16th of March, 2015.
13 hedge funds and large institutions have $14M invested in Allergan Inc in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.
17% less capital invested
Capital invested by funds: $16.8M → $14M (-$2.83M)
24% less funds holding
Funds holding: 17 → 13 (-4)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DY
Dowling & Yahnke
San Diego,
California
|
+$75.2K |
| 2 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
+$56.4K |
| 3 |
CAM
Cubic Asset Management
Boston,
Massachusetts
|
+$4.86K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HHAA
Henry H. Armstrong Associates
Pittsburgh,
Pennsylvania
|
-$882K |
| 2 |
TFA
Toth Financial Advisory
Leesburg,
Virginia
|
-$700K |
| 3 |
LP
LMR Partners
London,
United Kingdom
|
-$633K |
| 4 |
LCP
Legacy Capital Partners
Milwaukee,
Wisconsin
|
-$524K |
| 5 |
CI
Chartist Inc
Seal Beach,
California
|
-$365K |
AGN Hedge Fund Activity: Q2 2017 in Review
13 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Allergan Inc (AGN) for Q2 2017, worth a combined $14M — down 17% from $16.8M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of AGN and 0 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 3 added.
The largest buyer was Dowling & Yahnke, adding an estimated $75.2K. The largest seller was Henry H. Armstrong Associates, exiting entirely with an estimated $882K sold.
- 13 institutional investors held Allergan Inc (AGN) as of Q2 2017, down from 17 in Q1 2017.
- Funds reported $14M of Allergan Inc stock for Q2 2017, down 17% quarter-over-quarter.
- 0 funds opened new Allergan Inc positions in Q2 2017 and 4 closed out, a net change of -4 holders.
- The largest Allergan Inc buyer in Q2 2017 was Dowling & Yahnke, an estimated $75.2K added.
- The largest Allergan Inc seller in Q2 2017 was Henry H. Armstrong Associates, an estimated $882K sold.
Based on aggregated 13F filings for Q2 2017.